Masanobu Obara

Title: Masanobu Obara: Innovator in Peptide and Collagen Research

Introduction

Masanobu Obara is a prominent inventor based in Hiroshima, Japan. He has made significant contributions to the field of biomedical research, particularly in the development of innovative treatments for skin conditions. His work focuses on the interaction between collagen and fibronectin, which is crucial for understanding various skin disorders.

Latest Patents

Masanobu Obara holds a patent for a peptide and collagen contraction inhibitor. This invention provides a collagen contraction inhibitor that contains a peptide comprising at least the amino acid sequence of Sequence ID No. 1, along with its pharmacologically acceptable derivatives and salts. The peptide specifically inhibits the binding between collagen and fibronectin through antagonistic action, offering a remarkable effect in the treatment of keloids and vulnera. He has 1 patent to his name.

Career Highlights

Masanobu Obara is associated with the Japan Science and Technology Corporation, where he continues to advance his research and innovations. His work has garnered attention for its potential applications in medical treatments, particularly in dermatology.

Collaborations

Masanobu has collaborated with notable colleagues, including Masaaki Ono and Katsutoshi Yoshizato. Their combined expertise has contributed to the success of their research initiatives.

Conclusion

Masanobu Obara's innovative work in peptide and collagen research highlights his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of skin conditions, showcasing the importance of continued research in this field.